Biomarker discovery sheds new light on heart attack risk of arthritis drugs

10 diciembre 2014

A class of drug for treating arthritis – all but shelved over fears about side effects – may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it. A new study sheds light on the 10-year-old question of how COX-2 inhibitors — a type of non-steroidal anti-inflammatory drug (NSAID) — can increase the risk of heart attack in some people.